456
Participants
Start Date
July 20, 2022
Primary Completion Date
February 1, 2024
Study Completion Date
July 1, 2024
Delayed second dose of oral cholera vaccine, Euvichol-Plus
The intervention arms (6 and 12 months) will modify the recommended interval for administration of the second vaccine dose, which will be extended to 6 and 12 months according to the intervention arm.
Oral cholera vaccine, Euvichol-Plus, according to manufacturer notice
"Euvichol-Plus, a WHO prequalified oral cholera vaccine, contains modified killed whole cell vaccine of formalin killed Vibrio cholerae strains of O1 Inaba, O1 Ogawa and O139.~In the control arm, participants will receive the Euvichol-Plus following the manufacturer recommendations: two doses administered orally 14 days apart for individuals aged ≥1 year."
Dixinn, Conakry
Lead Sponsor
Ministry of Health, Guinea
OTHER_GOV
Massachusetts General Hospital
OTHER
Médecins Sans Frontières, Belgium
OTHER
Epicentre
OTHER